Data is not available at this time.
Showa Chemical Industry Co., Ltd. operates in the specialty chemicals sector, specializing in diatomite and perlite filter aids under its Radiolite and Topco brands. These products are critical for liquid and gas filtration across industries such as food and beverage, pharmaceuticals, and water treatment. The company also supplies functional additives for coatings, agricultural chemicals, and industrial applications, leveraging its expertise in mineral processing. Headquartered in Tokyo and founded in 1930, Showa Chemical has established a niche presence in Japan and China, serving industrial clients with high-purity filtration solutions. Its market position is reinforced by proprietary technologies and a reputation for reliability in demanding filtration processes. While the company operates in a competitive global market, its focus on specialized applications and regional distribution networks provides stability. However, its growth potential may be constrained by limited geographic diversification and reliance on industrial demand cycles.
For FY 2024, Showa Chemical reported revenue of JPY 9.2 billion, with net income of JPY 584 million, reflecting a modest but stable profitability margin. Operating cash flow stood at JPY 826 million, supported by efficient working capital management. Capital expenditures were JPY 220 million, indicating restrained reinvestment relative to cash generation. The company maintains a disciplined cost structure, though its margins are influenced by raw material costs and industrial demand fluctuations.
Showa Chemical’s diluted EPS of JPY 55.11 underscores its ability to generate earnings despite its small scale. The company’s capital efficiency is adequate, with operating cash flow covering capital expenditures comfortably. However, its reliance on industrial markets limits earnings volatility, and its low beta (0.225) suggests relative insulation from broader market swings. The balance between debt and cash reserves will be critical for sustaining profitability.
The company holds JPY 3.15 billion in cash and equivalents against total debt of JPY 3.21 billion, indicating a balanced but leveraged position. Its net debt is minimal, providing flexibility, though the debt load could constrain aggressive expansion. The liquidity position appears stable, with sufficient cash to meet near-term obligations and moderate capital needs.
Showa Chemical’s growth is tied to industrial demand, with limited recent expansion. The dividend payout of JPY 6 per share reflects a conservative but shareholder-friendly policy, aligning with its stable cash flows. Future growth may depend on technological advancements or geographic diversification, though the company has not signaled major strategic shifts.
With a market cap of JPY 4.97 billion, the company trades at a modest valuation, reflecting its niche position and steady but unspectacular growth prospects. Investors likely view it as a stable, low-beta holding in the specialty chemicals sector, with limited upside unless operational or market conditions improve.
Showa Chemical’s strengths lie in its specialized filtration products and long-standing industry relationships. However, its outlook is tempered by reliance on industrial cycles and regional concentration. Strategic initiatives to expand into higher-growth applications or markets could enhance its position, but current operations suggest a steady, low-risk profile.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |